Loading cancer entity…
Loading cancer entity…
Clinical trials
51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07040280 | Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma | recruiting | Phase 2 | 120 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07477548 | A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies | not yet recruiting | Phase 2 | 67 | Yonsei UniversityOTHER | 0 | Mar 17, 2026 | clinicaltrials |
| NCT02809001 | The Effects of Autologous Fat Transfer on Preventing Expanded Skin From Expansion Failure | completed | Phase 1 / Phase 2 | 80 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00656227 |
Data updated 14 days agoSource updated Sep 15, 2026source: clinicaltrials
| unknown |
| Phase 2 |
| 239 |
| RenovoINDUSTRY |
| 1 |
| Apr 11, 2008 |
| clinicaltrials |